![Suzanne Thornton-Jones](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Suzanne Thornton-Jones
Conseiller Juridique Général chez
GENPREX, INC.
Profil
Suzanne Thornton-Jone currently works at Genprex, Inc., as Senior Vice President-Regulatory Affairs & Quality from 2023.
Dr. Thornton-Jone also formerly worked at Affinia Therapeutics, Inc., as VP-Regulatory Affairs & Project Team Lead and Tavanta Therapeutics, Inc., as Vice President & Head-Regulatory Affairs.
Dr. Thornton-Jone received her undergraduate degree, graduate degree, and doctorate degree from Virginia Commonwealth University.
Postes actifs de Suzanne Thornton-Jones
| Sociétés | Poste | Début |
|---|---|---|
| GENPREX, INC. | Conseiller Juridique Général | 22/08/2023 |
Anciens postes connus de Suzanne Thornton-Jones
| Sociétés | Poste | Fin |
|---|---|---|
Affinia Therapeutics, Inc.
 Affinia Therapeutics, Inc. BiotechnologyHealth Technology Develops adeno-associated virus gene therapies | Conseiller Juridique Général | - |
Tavanta Therapeutics, Inc.
 Tavanta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage pharmaceutical company developing a diverse pipeline of specialty drugs | Conseiller Juridique Général | - |
Formation de Suzanne Thornton-Jones
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
2
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Genprex, Inc.
 Genprex, Inc. Pharmaceuticals: MajorHealth Technology Develops molecular therapies for cancer treatment | Health Technology |
Virginia Commonwealth University
 Virginia Commonwealth University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Affinia Therapeutics, Inc.
Affinia Therapeutics, Inc. BiotechnologyHealth Technology Develops adeno-associated virus gene therapies | Health Technology |
Tavanta Therapeutics, Inc.
Tavanta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage pharmaceutical company developing a diverse pipeline of specialty drugs | Health Technology |
